Dr. Mark Delworth on Robotic Prostatectomy

Video

Mark Delworth, MD, a urologist and the medical director of the Minimally Invasive and Robotic Surgery Program at TriHealth Hospital, talks about the outcomes of robotic surgery for the treatment of prostate cancer.

Mark Delworth, MD, a urologist and the medical director of the Minimally Invasive and Robotic Surgery Program at TriHealth Hospital, talks about the outcomes of robotic surgery for the treatment of prostate cancer.

The biggest advantages of robotic prostatectomy are less pain and blood loss and shorter hospitalization and recovery time, says Delworth. Some studies have also shown that robotic surgeries improve pathological parameters, leading to a reduction in recurrence rates. However not every study has confirmed these findings.

There is also some question as to if robotic prostatectomies result in the same functional status outcomes as traditional surgeries, including sexual function and urinary control. Delworth feels that studies support that robotic surgery actually delivers better functional status outcomes.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD